C95.0

Applicable To

• Acute bilineal leukemia

• Acute mixed lineage leukemia

• Biphenotypic acute leukemia

• Stem cell leukemia of unclear lineage

Clinical Information

• A clonal malignant) hematopoietic disorder affecting the bone marrow and the peripheral blood. The malignant cells show minimal differentiation and are called blasts, either myeloid blasts myeloblasts) or lymphoid blasts lymphoblasts). According to the type of blasts present, acute leukemias are classified as acute myeloid leukemia aml) and precursor lymphoblastic or acute lymphoblastic leukemia all).

• A rapidly progressing cancer that starts in blood-forming tissue such as the bone marrow, and causes large numbers of white blood cells to be produced and enter the blood stream.

• An acute leukemia exhibiting cell features characteristic of both the myeloid and lymphoid lineages and probably arising from multipotent stem cells.

• An acute leukemia of ambiguous lineage characterized by blasts which coexpress myeloid and t or b lineage antigens or concurrent b and t lineage antigens. who, 2001)

• An acute leukemia of ambiguous lineage in which there is a dual population of blasts with each population expressing markers of a distinct lineage myeloid and lymphoid or b-and t-lymphocyte). who, 2001)

• Leukemia in which the involved cell shows little or no differentiation, usually consisting of blast cells; two types are distinguished, acute lymphocytic and acute myelogenous leukemia.

Details

• C95.0 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.

• The 2023 edition of ICD-10-CM C95.0 became effective on October 1, 2022.

• This is the American ICD-10-CM version of C95.0 – other international versions of ICD-10 C95.0 may differ.